- Poster presentation
- Open Access
Inactivation of cell associated-HIV-1 in breast milk by treatment with the alkyl sulfate microbicide sodium dodecyl sulfate (SDS)
© Tuaillon et al; licensee BioMed Central Ltd. 2009
- Published: 24 September 2009
- Sodium Dodecyl Sulfate
- Breast Milk
- ELISpot Assay
- Sodium Dodecyl Sulfate Concentration
- Alkyl Sulfate
Breast milk is recognized as a predominant mode of HIV-1 infection in infants. Cell-associated HIV-1 may be the main source of virus transmission during early phases of breast-feeding. We have previously observed that HIV-1-infected cells spontaneously producing virus persist in breast-milk from women under antiretroviral therapy. Treatment of expressed milk with a microbicide such as Sodium dodecyl sulfate (SDS) is proposed as a simple and safe option to inactivate both cell free and cell associated HIV-1 when formula feeding is not practicable. However, the effect of SDS on spontaneously HIV-1-producing CD4+T cells in breast milk has not been fully explored.
In this report human milk was spiked by HIV-1-infected cells and treated with increasing exposure time and SDS concentration. CD4+T cell apoptosis and death, cell-associated HIV-1 RNA production, and spontaneous HIV-1-Ag cell secretion were quantified after SDS treatment.
By comparison with results previously reported using an infectivity model based on β-galactosidase MAGI cells1, we observed that a two fold higher SDS concentration was required to complete inactivation of HIV-1-Ag-secreting cells. This concentration remains in the reported safe limits for ingestion of SDS by children (1 g/kg/day). Regarding the possible occurrence of transmission to the infant after controlling cell-free virus in breast milk from women on antiretroviral therapy, SDS treatment of expressed breast milk may be an interesting strategy to optimized the prevention of HIV-1 pediatric transmission.
This article is published under license to BioMed Central Ltd.